Whether you are approaching AOD-9604 for the first time or refining an existing protocol, the information here comes from clinical research, established protocols, and practical application
THE LANDMARK TRIAL PENN STATE, 6 MONTHS, PEER-REVIEWED: A 6-month randomized, double-blind, placebo-controlled human trial of 54 adults at Penn State University (Richie et al., European Journal of Nutrition, 2015) found that oral Setria L-Glutathione at 250 mg/day produced significant increases in whole-blood glutathione levels at 1, 3, and 6 months versus baseline establishing for the first time that oral glutathione is bioavailable in humans
Combination Therapy: Sitagliptin can be prescribed as a monotherapy or in combination with other diabetes medications, such as metformin or sulfonylureas
If your daily protein intake is low, protein will deliver more noticeable results than creatine